PMID: 6411788Oct 1, 1983Paper

Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall

Journal of the American College of Cardiology
J MehtaL Brigmon

Abstract

The precise mechanism of vasodilatory actions of nitroso-compounds is not clear. It has been suggested that these drugs might modulate release of the vasodilator, prostacyclin, from cultured endothelial cells and bovine arteries or potentiate actions of prostacyclin. This study was designed to examine the effects of nitroglycerin and nitroprusside on prostacyclin release from adult human vasculature. Saphenous vein ring preparations were incubated with nitroglycerin or nitroprusside and arachidonic acid, the substrate for prostacyclin. Vascular rings incubated with nitroglycerin released significantly more prostacyclin (measured as 6-keto-prostaglandin F1 alpha, a stable hydrolysis product of prostacyclin by radioimmunoassay) compared with the control vascular rings (p less than 0.02). This increase was observed at the therapeutic concentrations of nitroglycerin (5 to 10 ng/ml). However, incubation of saphenous vein rings with nitroprusside in concentrations as high as 1 microgram/ml was not associated with any increase in prostacyclin release. Prior incubation of vascular rings with the cyclooxygenase blocker, indomethacin, inhibited nitroglycerin-induced prostacyclin release. Incubation of vascular rings with the selective th...Continue Reading

References

Jun 24, 1978·Lancet·K SilberbauerM Winter
May 17, 1979·The New England Journal of Medicine·S Moncada, J R Vane
May 18, 1978·The New England Journal of Medicine·P Needleman, G Kaley
Feb 1, 1979·The Journal of Clinical Investigation·P NeedlemanA Raz
Nov 1, 1979·Annals of Internal Medicine·J N Cohn, L P Burke
Nov 1, 1972·The Journal of Clinical Investigation·S F VatnerD Franklin
Jul 1, 1968·Journal of Atherosclerosis Research·A PoplawskiS Niewiarowski
Jul 1, 1982·Journal of Cardiovascular Pharmacology·J Mehta, P Mehta
Nov 1, 1982·Prostaglandins, Leukotrienes, and Medicine·P MehtaD Hay
Feb 1, 1981·The American Journal of Cardiology·J Mehta, P Mehta
Jan 1, 1980·The American Journal of Cardiology·E MorcillioB Pitt
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman
Aug 1, 1981·The American Journal of Cardiology·J Mehta, P Mehta
May 13, 1982·The New England Journal of Medicine·J D DurrerD Durrer

❮ Previous
Next ❯

Citations

Aug 31, 2000·Biochemical and Biophysical Research Communications·K GhanamN Oudart
Sep 1, 1985·Basic Research in Cardiology·K Schrör
Mar 11, 1986·European Journal of Pharmacology·W R Kukovetz, S Holzmann
Dec 1, 1984·Journal of the American College of Cardiology·M D WinnifordL D Hillis
Dec 1, 1986·Journal of the American College of Cardiology·I SimonettiA L'Abbate
Apr 1, 1996·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M Di RosaL Sautebin
Jan 1, 1985·Circulation·R De CaterinaB B Weksler
Jul 14, 1999·Circulation·Y Y ChirkovJ D Horowitz
Nov 1, 2018·British Journal of Clinical Pharmacology·Kangbin Zhou, John D Parker
May 26, 2005·Pharmacological Reviews·Vincenzo MollaceDaniela Salvemini
Dec 1, 1992·Arthritis and Rheumatism·L I Kaplan
Jan 1, 1986·Acta Pharmacologica Et Toxicologica·J AhlnerK Bornfeldt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.